Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide in the UK: How People Are Accessing It and the Risks Retatrutide, the investigational triple hormone receptor agonist developed by Eli Lilly, has attracted significant public interest following promising Phase 2 trial data but it remains unlicensed in the UK
United StatesLouisianaOuachita ParishMonroeRejuvime Medical Partial Data by Foursquare
845 Lake Drive Issaquah, WA 98027
It is completely safe with no known side effects
Tablet, Sublingual, or Injection
In theory, this could pave the way for even greater efficacy for GLP-1 treatments while also achieving an important reduction in the currently high rate of adverse GI events
US$ 29.02
US$ 27.06
US$ 26.97
US$ 21.97
US$ 23.65
